Terms: = Liver cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Diagnosis
26 results:
1. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
2. The value of varying diffusion curvature MRI for assessing the microvascular invasion of hepatocellular carcinoma.
Zhang Y; Sheng R; Dai Y; Yang C; Zeng M
Abdom Radiol (NY); 2024 Apr; 49(4):1154-1164. PubMed ID: 38311671
[TBL] [Abstract] [Full Text] [Related]
3. Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma.
Cho EJ; Kim B; Yu SJ; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS; Yoon JH; Park T
Br J Cancer; 2024 Apr; 130(6):970-975. PubMed ID: 38278977
[TBL] [Abstract] [Full Text] [Related]
4. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Serra-Burriel M; Juanola A; Serra-Burriel F; Thiele M; Graupera I; Pose E; Pera G; Grgurevic I; Caballeria L; Piano S; van Kleef L; Reichert M; Roulot D; Pericàs JM; Schattenberg JM; Tsochatztis EA; Guha IN; Garcia-Retortillo M; Hernández R; Hoyo J; Fuentes M; Expósito C; Martínez A; Such P; Madir A; Detlefsen S; Tonon M; Martini A; Ma AT; Pich J; Bonfill E; Juan M; Soria A; Carol M; Gratacós-Ginès J; Morillas RM; Toran P; Navarrete JM; Torrejón A; Fournier C; Llorca A; Arslanow A; de Koning HJ; Cucchietti F; Manns M; Newsome PN; Hernáez R; Allen A; Angeli P; de Knegt RJ; Karlsen TH; Galle P; Wong VW; Fabrellas N; Castera L; Krag A; Lammert F; Kamath PS; Ginès P;
Lancet; 2023 Sep; 402(10406):988-996. PubMed ID: 37572680
[TBL] [Abstract] [Full Text] [Related]
5. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract] [Full Text] [Related]
6. Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients.
Yip TC; Wong VW; Lai MS; Lai JC; Tse YK; Liang LY; Hui VW; Chan HL; Wong GL
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2864-2875.e16. PubMed ID: 36828301
[TBL] [Abstract] [Full Text] [Related]
7. SUVmax-to-HU ratio in diagnosis of hepatic metastases of colon cancer on FDG PET/CT. A new semiquantitative parameter.
Ayaz UY; Ayaz S
Ann Ital Chir; 2023; 94():27-35. PubMed ID: 36810357
[TBL] [Abstract] [Full Text] [Related]
8. Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions.
Lu W; Wang L; Lou J; Tang K
Tumori; 2023 Jun; 109(3):307-313. PubMed ID: 35815545
[TBL] [Abstract] [Full Text] [Related]
9. Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.
Niu XK; He XF
World J Gastroenterol; 2021 Jan; 27(2):189-207. PubMed ID: 33510559
[TBL] [Abstract] [Full Text] [Related]
10. Cyclic Peptide Mimotopes for the Detection of Serum Anti-atic Autoantibody Biomarker in Hepato-Cellular Carcinoma.
Heo CK; Hwang HM; Lim WH; Lee HJ; Yoo JS; Lim KJ; Cho EW
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352757
[TBL] [Abstract] [Full Text] [Related]
11. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract] [Full Text] [Related]
12. Energy-dense nutrient-poor snacks and risk of non-alcoholic fattyliver disease: a case-control study in Iran.
Yari Z; Cheraghpour M; Aghamohammadi V; Alipour M; Ghanei N; Hekmatdoost A
BMC Res Notes; 2020 Apr; 13(1):221. PubMed ID: 32299509
[TBL] [Abstract] [Full Text] [Related]
13. Association Between PNPLA3 rs738409 C>G Variant and liver-Related Outcomes in Patients With Nonalcoholic Fatty liver Disease.
Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
[TBL] [Abstract] [Full Text] [Related]
14. Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic cancer Therapy.
Bonafede MM; Korytowsky B; Singh P; Cai Q; Cappell K; Jariwala-Parikh K; Sill B; Parikh ND
J Gastrointest Cancer; 2020 Mar; 51(1):217-226. PubMed ID: 31011982
[TBL] [Abstract] [Full Text] [Related]
15. Costs of cancer Care Across the Disease Continuum.
Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical significance of preoperative biliary drainage for patients with moderate jaundice: a prospective non-randomized controlled study].
Lan Z; Tang X; Zhang J; Wang C
Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(2):93-5. PubMed ID: 25876892
[TBL] [Abstract] [Full Text] [Related]
17. Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis.
Wei C; Tan J; Xu L; Juan L; Zhang SW; Wang L; Wang Q
Tumour Biol; 2015 Feb; 36(2):983-90. PubMed ID: 25318600
[TBL] [Abstract] [Full Text] [Related]
18. Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site.
Molina R; Bosch X; Auge JM; Filella X; Escudero JM; Molina V; Solé M; López-Soto A
Tumour Biol; 2012 Apr; 33(2):463-74. PubMed ID: 22161237
[TBL] [Abstract] [Full Text] [Related]
19. Increased risk of cancer among gout patients: a nationwide population study.
Kuo CF; Luo SF; See LC; Chou IJ; Fang YF; Yu KH
Joint Bone Spine; 2012 Jul; 79(4):375-8. PubMed ID: 22088929
[TBL] [Abstract] [Full Text] [Related]
20. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.
Liu C; Shen J; Pan C; Yang L; Mou S; Wang H; Liang Y
Am J Clin Pathol; 2010 Aug; 134(2):235-41. PubMed ID: 20660326
[TBL] [Abstract] [Full Text] [Related]
[Next]
